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Abstract 
Background: hyperbaric bupivacaine is commonly used in regional 
anesthesia, especially for the subarachnoid blockade. Several studies 
demonstrated the efficacy of ropivacaine in different regional anesthesia 
techniques. Dexmedetomidine has been studied and shown to have synergism 
local anesthetics. In this study, we aimed to find the efficacy of 
dexmedetomidine in improving the analgesia quality and duration of the 
subarachnoid blockade in our hospital scenario. 
Materials and Methods: One hundred adult patients were divided into two 
groups of 50 each. Group A received 3 mL of 0.5% isobaric ropivacaine. 
Group B received 3 mL 0.5% isobaric ropivacaine was used for spinal 
anesthesia followed by a loading dose of IV dexmedetomidine. Group A 
received isotonic saline infusion.  
Results: The duration of the motor block in group A was 139.38±21.22 
minutes vs.179.13±31.18 minutes in group B (P<0.05). Duration of the 
sensory block in group A was 156.79 ± 33.00 minutes vs. 208.13±48.32 
minutes in group B (P<0.05), and the duration of the analgesia in group A 
was 168.69 ± 41.18 minutes vs. 278.57±34.65 minutes in group B (P<0.05). 
Conclusion: The use of IV dexmedetomidine improves analgesia quality and 
prolongs anesthesia duration in the subarachnoid block with 0.5% isobaric 
ropivacaine without any hemodynamic instability and with adequate sedation. 
Keywords: Spinal anesthesia, Ropivacaine, Dexmedetomidine, Postoperative 
analgesia 
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Introduction 
Spinal anesthesia is a common procedure carried out in 
the operation theatre and is carried out by injecting a 
local anesthetic solution into the cerebrospinal fluid in 
the region of lower lumbar intervertebral spaces. It 
creates an intense sensory, motor, and sympathetic 
block and provides excellent operating conditions for 
surgeries below the dermatomal level of the umbilicus 
(1, 2). Use of IV dexmedetomidine premedication in 
general anesthesia has been shown to provide sedation 
preoperatively, reduces intraoperative inhalational 
anesthetic requirements, intraoperative, and 
postoperative analgesia with good hemodynamic 
stability (3-6). In the central nervous system, the 
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highest number of alpha 2 adrenoreceptor receptors is 
present in locus ceruleus, presynaptic activation of 
theses in locus ceruleus leads to inhibition of 
noradrenaline release resulting in hypnotic and 
sedative effects (7-9). In the spinal cord, activation of 
alpha2 adrenoreceptor receptors at substantia 
gelatinosa leads to inhibition of nociception and 
release of substance P (10-12). 
Methods 
This study was conducted at Sri Siddhartha Medical 
College Hospital and Research Center, Tumkur 
(ERC/137/Inst/KR/2013/RR16). CONSORT 
guidelines were followed in this study. Computer-
based randomization was done (The easiest method is 
simple randomization. If you assign subjects into two 
groups A and B, you assign subjects to each group 
purely randomly for every assignment. Even though 
this is the most basic way, if the total number of 
samples is small, sample numbers are likely to be 
assigned unequally. For this reason, we recommend 
you to use this method when the total number of 
samples is more than 100). After taking written 
informed consent, a hundred patients between 20 and 
60 years of age, of ASA Class I and II, scheduled for 
elective lower limb surgeries were enrolled in the 
study. The investigator and the patient were blinded to 
the study. A third member of the department was 
employed to prepare the solutions to be used in the 
study. Infection at the site of spinal anesthesia, patients 
with uncontrolled hypertension and diabetes, any 
neurological or psychiatric diseases, and patients with 
bleeding or coagulation disorders were excluded from 
the study. 
The following formula was employed to arrive 
at the sample size. 
𝑆𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒 =




Z = Z value (e.g. 1.96 for 95% confidence 
level) 
p = percentage picking a choice expressed as a 
decimal 
(.5 used for sample size needed) 
c = confidence interval expressed as a decimal 
(e.g., .04 = ±4) 
The baseline, intraoperative, and postoperative 
hemodynamic changes at various time intervals were 
compared between the study groups using Chi-square 
test and unpaired t-test. Data validation and analysis 
was carried out by SPSS version 11.0. All the P values 
< 0.05 were considered significant statistically. 
The subjects were randomly allocated using a 
computer-generated sequence, into either of the 
groups. Preoperatively all study patients have advised 
8 hours’ nil per oral. As per the hospital protocols, all 
patients received Tab. Ranitidine 150 mg orally on the 
night before surgery at 10 pm also at 5.30 AM with a 
sip of water as premedication. The patients were 
transferred to the operation theatre at 8.30 AM. 
Intravenous access was achieved with an 18G cannula. 
All patients were preloaded with Ringer’s Lactate 10 
mL/Kg, 15 minutes before the surgery. In the operating 
theatre, standard monitoring viz. oxygen saturation 
(SpO2) heart rate (HR), non – invasive blood pressure 
(NIBP), electrocardiogram (ECG) were attached and 
baseline hemodynamic parameters were recorded. 
Under aseptic precautions, using a 25G Quincke spinal 
needle, the subarachnoid block was performed at L3 – 
L4 inter-space in the midline with 0.5% isobaric 
ropivacaine (Neon Pharmaceuticals, India) was 
administered at the rate of 0.2 mL/sec.  
Group A received 3 mL of 0.5% isobaric 
ropivacaine and normal saline infusion. Group B 
received 3 mL 0.5% isobaric ropivacaine, thirty 
minutes later loading dose of dexmedetomidine 
1mcg/Kg was infused over 30 min followed by the 
maintenance dose of 0.3 mcg/kg/hr IV 
dexmedetomidine infused till the end of surgery 
(AKAS Syringe Pump). SpO2, HR, Systolic blood 
pressure (SBP), Diastolic blood pressure (DBP) and 
Mean arterial pressure (MAP) were recorded 
preoperatively and after performing the subarachnoid 
block, every 5 minutes till the end of surgery after 
which they were transferred to the recovery room 
where they were monitored up to 90 minutes.  
Modified Bromage Scale was employed to 
assess the level of motor block. Time taken for 
regression of motor block to Modified Bromage Scale 
1 was considered. Using pinprick bilaterally at 
midclavicular line, time of onset of sensory block, level 
of sensory block, and sensory block duration were 
recorded. Time taken to reach L5/S1 dermatome was 
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considered as recovery time for the sensory block. 
Postoperatively, the Modified Bromage Scale and the 
sensory level were recorded every 15 minutes until the 
patients were discharged from the post-anesthesia care 
unit. The level of pain was assessed by The Visual 
Analog Scale (VAS). VAS greater than 4 was 
considered as cut off point to treat pain. IV 
Paracetamol 1-gram slow infusion was administered 
for rescue analgesia (13, 14). The level of sedation was 
assessed by The Ramsay Sedation Score. A score 
greater than 4 was considered as excessive sedation. 
Any decrease in MAP of 20% from the baseline was 
treated with a bolus dose of 6 mg IV ephedrine and 
infusion of intravenous fluids. HR less than 50/min 
was treated with IV bolus 0.6 mg atropine. The 
baseline, intraoperative, and postoperative 
hemodynamic changes at various time intervals were 
compared between the study groups using Chi-square 
test and unpaired t-test. Data validation and analysis 
was carried out by SPSS Version 16.0. All the P values 
< 0.05 were considered significant statistically. 
Results 
The demographic data of the two study groups were 
comparable (Table 1). Baseline parameters (Table 2) 
and the mean duration of surgery (Table 3). Both the 
duration of motor block and sensory block were 
prolonged in Group B compared to Group A (p<0.001) 
(Table 4). The two-segment regression in Group A was 
74.9±8.64 minutes whereas in Group B it was 
99.1±10.79 minutes (P<0.001) (Table 5). The time 
taken for rescue analgesia was prolonged in Group B 
compared to Group A (P<0.001) (Table 5). The 
hemodynamic comparisons are shown in Figures 1 to 
7. 
In Group A, the mean sedation score was 2 at 
the beginning of the postoperative period and 1 at the 
end of 90 minutes whereas in Group B, the mean 
sedation score was 2.18 at the beginning of the 
postoperative period and 2.08 at 90 minutes. The 
Ramsay sedation score was higher in Group B 
(p<0.05). 
In Group A, the VAS score was 2.23 at the 
beginning of the postoperative period and gradually 
increased to 4.83 at 90 minutes whereas, in Group B, 
the VAS score was 0.61 at the beginning of the 
postoperative period and 2.91 at 90 minutes. The pain 
scores were higher in Group A (P<0.05). Hence, it is 
evident from the above observations that intravenous 
dexmedetomidine administered intraoperatively 
provides adequate sedation and analgesia that 
continues even in the postoperative period without 
causing any respiratory depression. 
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Intraoperatively, 7 patients had bradycardia and hypotension in 11 patients in Group A, whereas in 
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Figure 4: Postoperative HR at various intervals. 
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Group B, 3 patients had bradycardia and 3 patients had hypotension. The two groups did not differ 
 
Figure 5: Postoperative SBP at various intervals. 
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significantly concerning intraoperative hemodynamics 
at any interval of time and SpO2 at any time (P>0.05; 
Figure 8). 
In Group A, 1(2%) patient had vomiting 
whereas, in Group B, none were observed. It was 
treated with IV Ondansetron 4 mg. In Group A, 1(2%) 
of patients experienced shivering in the postoperative 
period. It was treated with IV Pheniramine Maleate 
45.5 mg whereas, in Group B, none was observed. 
The full Study consort flow diagram is 
demonstrated in Figure 8. 
Discussion 
Spinal anesthesia provides good operating conditions 
for lower abdominal and lower limb surgeries. Many 
additives and adjuvants have been tried and tested. 
Intrathecal adjuvants like morphine, fentanyl, 
sufentanil, neostigmine, ketamine, midazolam, 
magnesium sulfate, clonidine, and dexmedetomidine, 
have been used to improve analgesia quality and 
 
Figure 8. Postoperative SpO2 at various intervals. 
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Table 1: Demographic data. 
Parameter Group A Group B p value 
Age (Years) 43.36±7.50 45.31±8.26 0.648 
BMI (kg/m2) 20.24±1.72 19.98±2.11 0.259 
Sex (Male/Female) 24:27 23:27 -  
 
Table 2: Baseline Hemodynamic Parameters. 
Parameter Group A Group B P value 
HR 81.68 76.18 ˂0.05 
SBP 128.73 127.15 ˂0.05 
DBP 76.75 82.44 ˂0.05 
MAP 98.33 96.17 ˂0.05 
SpO2 100 99.88 ˂0.05 
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anesthesia duration in spinal anesthesia. In a study 
done by Balwinder Kaur Rekhiet al, it was found that 
intravenous dexmedetomidine prolonged the effect of 
ropivacaine (3mg) (15). 
In a study done by PDW Fettes et al, plain and 
hyperbaric solutions of ropivacaine for spinal 
anesthesia were compared and it was shown that 
isobaric ropivacaine provided adequate analgesia for 
lower limb procedures. 16 In a study done by J 
Chinnappa et al, perineural dexmedetomidine with 
ropivacaine provided prolonged postoperative 
analgesia, hastened the onset of sensory and motor 
block, and prolonged the duration of the 
supraclavicular brachial plexus block (17). 
Ropivacaine causes reversible inhibition of 
sodium ion influx, and thereby blocks impulse 
conduction in nerve fibers. This action is potentiated 
by dose-dependent inhibition of potassium channels. 
Ropivacaine is less lipophilic than bupivacaine and is 
less likely to penetrate large myelinated motor fibers; 
therefore, it has a selective action on the pain – 
transmitting A, δ, and, C nerves rather than Aβ fibers, 
which are involved in motor function. Ropivacaine has 
been shown to inhibit platelet aggregation in plasma at 
concentrations of 3.75 and 1.88 mg/mL, which 
correspond to those that, could occur in the epidural 
space during infusion (18). 
Adrenergic receptors were originally 
differentiated into α and β receptors based on the rank 
order of potency of various natural and synthetic 
catecholamines in different physiologic preparations. 
It was believed that activation of either α- or β- 
adrenergic receptors produced excitatory effects in 
some tissues and inhibitory effects in others. Later, a 
subclass of α adrenoceptor was discovered that 
regulates the release of neurotransmitters. From this, it 
was inferred that the receptor is located at the 
presynaptic site. However, the classification of the 
receptors based on anatomic location alone is 
problematic, because α2receptors have also been found 
at postsynaptic and extrasynaptic sites. Presynaptic 
α2 receptors may be of the greatest clinical import 
because they regulate the release of norepinephrine and 
adenosine triphosphate through a negative feedback 
mechanism. 
Dexmedetomidine, an imidazole compound, is 
the pharmacologically active dextranomer of 
medetomidine that displays specific and selective α2-
adrenoceptor agonists. The mechanism of action is 
unique and differs from those of currently used 
sedative agents, including clonidine. Activation of the 
receptors in the brain and spinal cord inhibits neuronal 
firing, causing hypotension, bradycardia, sedation, and 
analgesia. The responses to activation of the receptors 
in other areas include decreased salivation, decreased 
secretion, and decreased bowel motility in the 
gastrointestinal tract; contraction of vascular and other 
smooth muscle; inhibition of renin release, increased 
Table 4: Comparison of sensory and motor blockade (minutes). 
Parameter Group A Group B P value 
Sensory Blockade 156.79 ± 33.00 . 208.13 ± 48.32 < 0.001 
Motor Blockade 139.38 ± 21.22 179.13 ± 31.18 < 0.001 
 
Table 3: Duration of Surgery (minutes). 
Group A Group B P value 
97.11±24.79 97.44±26.19 0.95 
 
Table 5: Two segment regression (minutes). 
Group A Group B P value 
74.9 ± 8.64 99.1 ± 10.79 < 0.001 
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glomerular filtration, and increased secretion of 
sodium and water in the kidney; decreased intraocular 
pressure, and decreased insulin release from the 
pancreas (19). 
In recent studies, dexmedetomidine has been 
shown to have a synergistic action with local 
anesthetics in prolonging the sensory and motor 
blocks, with good sedation effect and hemodynamic 
stability. Different adjuvants like opioids, adrenergic 
agents, GABA agonists, N-Methyl-D-aspartate 
receptor (NMDA) antagonist, calcium channel 
antagonist, cholinesterase inhibitors have been used to 
prolong spinal anesthesia, with reduced postoperative 
analgesic requirements. Also, these agents help to allay 
the fear and anxiety of the patient by their sedative 
effects. 
As the study was conducted in a tertiary care 
center, the people visiting the hospital were of poor 
socioeconomic and educational status, we found it 
difficult to accurately explain the nature and purpose 
of this study. These are inherent problems which were 
faced by our colleagues in other specialties too. We 
endeavored to partially overcome this by using simple 
spoken language and prior explanation to attendees of 
the subjects. 
 
Figure 8: Study consort flow diagram. 
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Conclusion 
Ropivacaine has a significantly higher threshold for 
cardiotoxicity and CNS toxicity than bupivacaine in 
animals and healthy volunteers and is a good 
alternative to bupivacaine. The addition of an adjuvant 
to ropivacaine enhances its safety profile by providing 
adequate postoperative analgesia. 
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